Stay updated with breaking news from Explora Biolabs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Second-Quarter Revenue of $973.1 Million –– Second-Quarter GAAP Earnings per Share of $2.13 and Non-GAAP Earnings per Share of $2.77 –– Reduces 2022 Guidance –WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CRL--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter...
(PLX AI) - Charles River Q1 revenue USD 913.9 million vs. estimate USD 910 million.• Q1 net income USD 93 million• Q1 adjusted EPS USD 2.75 vs. estimate USD 2.72• Q1 EPS USD 1.81• Reported revenue growth
Charles River Laboratories International, Inc. (NYSE:NYSE:CRL) Q1 2022 Earnings Conference Call May 04, 2022 09:30 AM ET Company Participants Todd Spencer - VP, IR James Foster - Chairman,...
(PLX AI) - Charles River Laboratories acquired Explora BioLabs Holdings, Inc., a premier provider of contract vivarium research services, for $295 million in cash. • Explora BioLabs had annual revenue
– Expands Charles River Accelerator and Development Lab (CRADL™) Footprint Providing Clients with Full-Service, Turnkey Research Space –– Adds More Than 15 Vivarium Facilities Across Three Key U.S. Biohubs –– Continued Expansion Expected in 2022 –WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #acquisition--Charles River L...